UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.

Altre lingue Universal Vision Biotechnology Co., Ltd.

Azioni

3218

TW0003218004

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
255,5 ^TWD	-1,73%		-5,55%	-7,76%

14/03	Universal Vision Biotechnology Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Universal Vision Biotechnology Co., Ltd. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024	13/03
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023	10/08/23
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/06/23
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23
Health Care Down on Mixed Earnings Prospects - Health Care Roundup	17/01/23
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes	20/10/22
Universal Vision Biotechnology : Clarification of mass media reporting	16/08/22
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company	12/08/22
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer	12/08/22
Universal Vision Biotechnology : The Company is invited to Citi's investor conference call for 1H2022 earnings	11/08/22
Universal Vision Biotechnology : Announcement of 2Q2022 consolidated financial reports approved by the Board of Directors	11/08/22
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company	23/06/22
Universal Vision Biotechnology : Announcement of important resolutions of the Company's 2022 General Shareholders'Meeting	23/06/22
Universal Vision Biotechnology : The Company is invited to Fubon Securities’ 2022Q2 Investment Forum Online	24/05/22
Universal Vision Biotechnology : The Company is invited to Yuanta Securities’ 2022Q2 Investment Forum Online	24/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Universal Vision Biotechnology Co., Ltd.

Azioni

3218

TW0003218004

Altre lingue

Filtri